Skip to content

Study TO Rule out efficasy Between Amalaki Churna And Lodhra Churna In The Management Of Shwetpradara (Leucorrhea)

A COMPARATIVE CLINICAL TRIAL DETERMINE THE EFFICACY OF AMALAKI CHURNA AND LODHRA CHURNA IN THE MANAGEMENT OF SHWETPRADARA (LEUCORREA) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100099
Enrollment
60
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Sponsors

Dr.Sandeep Natha Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group 18-35 years 2) Female Patients having symptoms - Yoni kandu (itching vulva) ,Yoni daha (burning sensation of vulva),Shwetasrava(WhiteVaginalDischarge) ,Daurgandhya(Foul-smelling of discharge),Katishool (Backache) 3) Willing for participation or ready to give Informed consent.

Exclusion criteria

Exclusion criteria: 1)Female Patients aged below 18 years and above 35 years will be excluded. 2)K/C/O women with Diabetes Mellitus. 3)Pregnant & lactating mothers. 4) K/C/O C.A. of genital organs, uterine tumor or uterine Prolapse 5)K/C/O Sexually transmitted diseases . 6) patient with K/C/O systemic diseases like HIV and severe Anemia.

Design outcomes

Primary

MeasureTime frame
Amalaki Churna Is Significantly Effective Than Lodhra Churna In The Management Of ShwetpradaraTimepoint: 7 days

Secondary

MeasureTime frame
Decrease Symptoms Of ShwetpradaraTimepoint: 7 Days

Countries

India

Contacts

Public ContactDr Vidhya Sarode

Ashvin Rural Ayurved College Manchi Hill Sangamner

sandeeptijadhav7747@gmail.com9146589877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026